Your browser doesn't support javascript.
loading
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.
Chalandon, Yves; Mamez, Anne-Claire; Giannotti, Federica; Beauverd, Yan; Dantin, Carole; Mahne, Elif; Mappoura, Maria; Bernard, Fanette; de Ramon Ortiz, Carmen; Stephan, Caroline; Morin, Sarah; Ansari, Marc; Simonetta, Federico; Masouridi-Levrat, Stavroula.
Afiliação
  • Chalandon Y; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: yves.chalandon@hcuge.ch.
  • Mamez AC; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Giannotti F; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Beauverd Y; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Dantin C; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Mahne E; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Mappoura M; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Bernard F; Cansearch Research platform for pediatric oncology and hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland; Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospital
  • de Ramon Ortiz C; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Stephan C; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Morin S; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Ansari M; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Cansearch Research platform for pediatric oncology and hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland; Division of Pediatric Oncology and Hematology, Depar
  • Simonetta F; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Masouridi-Levrat S; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
Transplant Cell Ther ; 28(11): 765.e1-765.e9, 2022 11.
Article em En | MEDLINE | ID: mdl-35953029
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article